129 related articles for article (PubMed ID: 36004691)
21. LncRNA CASC15 promotes the proliferation of papillary thyroid carcinoma cells by regulating the miR-7151-5p/WNT7A axis.
Bai D; Guo C; Wang A; Pang G; Gao J; Wang C; Zhao D; Yang J; Ren J
Pathol Res Pract; 2021 Sep; 225():153561. PubMed ID: 34325316
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA DUXAP8 promotes the cell proliferation, migration, and invasion of papillary thyroid carcinoma via miR-223-3p mediated regulation of CXCR4.
Liu Y; Zhang H; Wang H; Du J; Dong P; Liu M; Lin Y
Bioengineered; 2021 Dec; 12(1):496-506. PubMed ID: 33522355
[TBL] [Abstract][Full Text] [Related]
23. MiR-200c promotes papillary thyroid cancer cell proliferation, migration, and invasion by downregulating PTEN.
Guo K; Wang J; Shu L; Zhou G
Tissue Cell; 2021 Dec; 73():101647. PubMed ID: 34543800
[TBL] [Abstract][Full Text] [Related]
24. Long noncoding RNA NEAT1 regulate papillary thyroid cancer progression by modulating miR-129-5p/KLK7 expression.
Zhang H; Cai Y; Zheng L; Zhang Z; Lin X; Jiang N
J Cell Physiol; 2018 Oct; 233(10):6638-6648. PubMed ID: 29319165
[TBL] [Abstract][Full Text] [Related]
25. LncRNA HAGLROS contribute to papillary thyroid cancer progression by modulating miR-206/HMGA2 expression.
Zeng Z; Tang S; Chen L; Hou H; Liu Y; Li J
Aging (Albany NY); 2023 Dec; 15(24):14930-14944. PubMed ID: 38112616
[TBL] [Abstract][Full Text] [Related]
26. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer.
Gao H; Sun X; Wang H; Zheng Y
Cell Cycle; 2020 May; 19(10):1186-1199. PubMed ID: 32306838
[TBL] [Abstract][Full Text] [Related]
28. lncRNA HCG22 regulated cell growth and metastasis of papillary thyroid cancer via negatively modulating miR-425-5p.
Cao X; Ma C; Wu Y; Huang J
Endokrynol Pol; 2024; 75(1):20-26. PubMed ID: 38497386
[TBL] [Abstract][Full Text] [Related]
29. lncRNA RPL34-AS1 inhibits cell proliferation and invasion while promoting apoptosis by competitively binding miR-3663-3p/RGS4 in papillary thyroid cancer.
Ji L; Fan X; Zhou F; Gu J; Deng X
J Cell Physiol; 2020 Apr; 235(4):3669-3678. PubMed ID: 31587286
[TBL] [Abstract][Full Text] [Related]
30. LncRNA
Nian R; Li W; Li X; Zhang J; Li W; Pan F; Cheng J; Jin X
Arch Endocrinol Metab; 2023 Jan; 67(1):55-63. PubMed ID: 35929906
[TBL] [Abstract][Full Text] [Related]
31. miR-744-5p mediates lncRNA HOTTIP to regulate the proliferation and apoptosis of papillary thyroid carcinoma cells.
Yuan Q; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zheng J; Lu X
Exp Cell Res; 2020 Jul; 392(1):112024. PubMed ID: 32335029
[TBL] [Abstract][Full Text] [Related]
32. LncRNA SNHG4 promotes osteosarcoma proliferation and migration by sponging miR-377-3p.
Huang YF; Lu L; Shen HL; Lu XX
Mol Genet Genomic Med; 2020 Aug; 8(8):e1349. PubMed ID: 32537941
[TBL] [Abstract][Full Text] [Related]
33. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
[TBL] [Abstract][Full Text] [Related]
34. LncRNA SNHG4 promotes tumour growth by sponging miR-224-3p and predicts poor survival and recurrence in human osteosarcoma.
Xu R; Feng F; Yu X; Liu Z; Lao L
Cell Prolif; 2018 Dec; 51(6):e12515. PubMed ID: 30152090
[TBL] [Abstract][Full Text] [Related]
35. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67.
Liu ZM; Wu ZY; Li WH; Wang LQ; Wan JN; Zhong Y
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3421-3430. PubMed ID: 31081096
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA ACTA2-AS1 suppresses metastasis of papillary thyroid cancer via regulation of miR-4428/KLF9 axis.
Wu S; Zhu J; Jiang T; Cui T; Zuo Q; Zheng G; Li G; Zhou J; Chen X
Clin Epigenetics; 2024 Jan; 16(1):10. PubMed ID: 38195623
[TBL] [Abstract][Full Text] [Related]
37. METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer.
Zhang X; Li D; Jia C; Cai H; Lv Z; Wu B
Cell Death Dis; 2021 Jun; 12(6):617. PubMed ID: 34131102
[TBL] [Abstract][Full Text] [Related]
38. lncRNA SNHG4 modulates colorectal cancer cell cycle and cell proliferation through regulating miR-590-3p/CDK1 axis.
Zhou Z; Tan F; Pei Q; Li C; Zhou Y; Li Y; Pei H
Aging (Albany NY); 2021 Mar; 13(7):9838-9858. PubMed ID: 33744866
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA LINC00173 is downregulated in cervical cancer and inhibits cell proliferation and invasion by modulating the miR-182-5p/FBXW7 axis.
Zhang J; Zhou M; Zhao X; Wang G; Li J
Pathol Res Pract; 2020 Aug; 216(8):152994. PubMed ID: 32402537
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis.
Zhuang X; Tong H; Ding Y; Wu L; Cai J; Si Y; Zhang H; Shen M
Cell Death Dis; 2019 Aug; 10(8):620. PubMed ID: 31409775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]